JREG:XETRA:XETRA-JPMorgan ETFs (Ireland) ICAV - Global Research Enhanced Index Equity UCITS ETF - USD (acc) (EUR)

ETF | Others |

Last Closing

USD 45.07

Change

0.00 (0.00)%

Market Cap

USD 0.23B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.27 (-0.51%)

USD 577.24B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.09 (-0.55%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.14 (-0.49%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.12 (-0.40%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.38 (-1.53%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.06 (+0.13%)

USD 112.46B
8R80:XETRA Amundi Index Solutions - Amund..

-1.44 (-0.95%)

USD 112.09B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.24 (-0.46%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-6.70 (-1.22%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.03 (-0.11%)

USD 79.79B

ETFs Containing JREG:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.79% 86% B+ 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.79% 86% B+ 84% B
Trailing 12 Months  
Capital Gain 26.57% 83% B 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.57% 83% B 82% B
Trailing 5 Years  
Capital Gain 100.27% 95% A 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 100.27% 95% A 90% A-
Average Annual (5 Year Horizon)  
Capital Gain 14.35% 88% B+ 84% B
Dividend Return 14.35% 88% B+ 83% B
Total Return N/A 41% F 52% F
Risk Return Profile  
Volatility (Standard Deviation) 14.29% 41% F 52% F
Risk Adjusted Return 100.39% 97% N/A 97% N/A
Market Capitalization 0.23B 51% F 45% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.